Concepedia

Destiny Omili

DO

Statistics

Publications

6

Citations

130

H-Index

6

Active since

2022

Affiliations

University of Maryland, Baltimore(Current)

U-M Rogel Cancer Center

Stanford University

Sidney Kimmel Comprehensive Cancer Center

University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center

Destiny Omili is an author at University of Maryland, Baltimore specializing in life sciences, immunology, and vaccine-induced antibody responses.

ORCID

Publications per year

2022–2025

6

Publications

6

Systematic single amino acid affinity tuning of CD229 CAR T cells retains efficacy against multiple myeloma and eliminates on-target off-tumor toxicity

Erica R. Vander Mause, Jillian M. Baker, Kenneth A. Dietze et al. · Science Translational Medicine · 2023 · 35 citations

, , +17

Vaccine-induced T-cell responses against SARS-CoV-2 and its Omicron variant in patients with B cell–depleted lymphoma after CART therapy

Djordje Atanackovic, Tim Luetkens, Destiny Omili et al. · Blood · 2022 · 31 citations · Full text

, , +17

Humoral immunity against SARS‐CoV‐2 variants including omicron in solid organ transplant recipients after three doses of a COVID‐19 mRNA vaccine

Kapil Saharia, Jennifer Husson, Silke V. Niederhaus et al. · Clinical & Translational Immunology · 2022 · 27 citations · Full text

, , +15

T cell responses against SARS-CoV-2 and its Omicron variant in a patient with B cell lymphoma after multiple doses of a COVID-19 mRNA vaccine

Djordje Atanackovic, Robert J. Kreitman, Jeffrey I. Cohen et al. · Journal for ImmunoTherapy of Cancer · 2022 · 14 citations · Full text

, , +17

Immune-mediated facial nerve paralysis in a myeloma patient post B-cell maturation antigen-targeted chimeric antigen receptor T cells

Yamini K. Kathari, Haroon Ahmad, Michael E. Kallen et al. · Haematologica · 2023 · 12 citations · Full text

, , +12

1–5 of 6